Command Palette

Search for a command to run...

Clinical Trials · NCT04687514

Effects of Glucagon-Like Peptide-1 Analogs on Sexuality

CompletedPhase 2Dulaglutide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
University Hospital, Basel, Switzerland
Enrollment
26
Start date
May 2021
Locations
1 site, Switzerland
Primary endpoint
Change in sexual functioning, assessed with the German version of the Massachusetts General Hospital - Sexual Functioning Questionnaire (MGH-SFQ).
View Dulaglutide compound reference